There are 15 resources available
Welcome and opening
Presenter: E. Castro, ES and I. Ray-Coquard, FR
Session: Welcome and opening
Resources:
Slides
Webcast
Defects in DNA repair mechanisms across tumour types
Presenter: N. Naoun, FR
Session: Session 1 – General concepts
Resources:
Slides
Webcast
Molecular biomarkers predicting PARPi efficacy
Presenter: I. Labidi-Galy, CH
Session: Session 1 – General concepts
Resources:
Slides
Webcast
Primary versus secondary resistance to PARPi
Presenter: I. McNeish, UK
Session: Session 1 – General concepts
Resources:
Slides
Webcast
Ovarian cancer
Presenter: I. Ray-Coquard, FR
Session: Session 2 – Recent advances in PARP inhibition results in approved indications and other models
Resources:
Slides
Webcast
Breast cancer
Presenter: F. André, FR
Session: Session 2 – Recent advances in PARP inhibition results in approved indications and other models
Resources:
Slides
Webcast
Prostate cancer
Presenter: E. Castro, ES
Session: Session 2 – Recent advances in PARP inhibition results in approved indications and other models
Resources:
Slides
Webcast
Pancreatic cancer
Presenter: T. Golan, IL
Session: Session 2 – Recent advances in PARP inhibition results in approved indications and other models
Resources:
Slides
Other models
Presenter: N. Naoun, FR
Session: Session 2 – Recent advances in PARP inhibition results in approved indications and other models
Resources:
Slides
Shared experience of PARPi in the metastatic setting: Prostate and ovary examples
Presenter: E. Castro, ES and I. McNeish, UK
Session: Session 3 – Comparing efficacy of PARP inhibition across tumour types
Resources:
Slides
Webcast